EcoDrugPlus

Ensembl ID : ENSODEG00000014956
Gene Symbol: -
Cross references: -
187 Possible Orthologues:

Ensembl ID : ENSODEG00000002775
Gene Symbol: -
Cross references: -
276 Possible Orthologues:

Ensembl ID : ENSODEG00000003105
Gene Symbol: -
Cross references: -
204 Possible Orthologues:

Ensembl ID : ENSODEG00000013241
Gene Symbol: -
Cross references: -
450 Possible Orthologues:

Ensembl ID : ENSODEG00000013900
Gene Symbol: -
Cross references: -
202 Possible Orthologues:

Ensembl ID : ENSODEG00000007629
Gene Symbol: -
Cross references: -
113 Possible Orthologues:

Ensembl ID : ENSODEG00000002911
Gene Symbol: -
Cross references: -
65 Possible Orthologues:

Ensembl ID : ENSODEG00000018993
Gene Symbol: -
Cross references: -
76 Possible Orthologues:

Ensembl ID : ENSODEG00000019802
Gene Symbol: -
Cross references: -
382 Possible Orthologues:

Ensembl ID : ENSODEG00000019798
Gene Symbol: -
Cross references: -
177 Possible Orthologues:

Ensembl ID : ENSODEG00000000416
Gene Symbol: -
Cross references: -
251 Possible Orthologues:

Ensembl ID : ENSODEG00000019764
Gene Symbol: -
Cross references: -
382 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).